Business
BullFrog AI CEO Vin Singh to Present at the Gujarati Physicians Convention 2023
More than 1,000 physicians expected to attend the Continuing Medical Education program, where this year’s scientific program theme is “Futuristic Medicine”
About this update from Bullfrog Ai Holdings, Inc.
[{"type":"text","content":"More than 1,000 physicians expected to attend the Continuing Medical Education program, where this year’s scientific program theme is “Futuristic Medicine”\nGAITHERSBURG, Md., June 09, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) (\"BullFrog AI\" or the \"Company\"), a precision medicine company using AI and machine learning to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development, today announced its CEO Vin Singh will present at the Gujarati Physicians Convention in Atlantic City, New Jersey on June 10, 2023 at 11 a.m. ET. The Gujarati Physicians Convention is an annual event held by the Baroda Medical College Alumni Association and is part of Continuing Medical Education (CME). This year’s scientific program theme is “Futuristic Medicine.” The convention brings together Gujarati-American physicians from all over the United States to network, learn about new medical advances, and celebrate their Gujarati heritage. More than 1,000 physicians are expected to attend the 2023 convention, which features a variety of speakers, CME workshops, and social events. Speakers will include leading experts in a variety of medical fields, including cardiology, oncology, and pediatrics. Workshops will cover topics such as medical coding, patient safety, and stress management. About BullFrog AI BullFrog AI is a precision medicine company using AI and machine learning to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development using its proprietary bfLEAP™ artificial intelligence platform. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics. For more information visit BullFrog AI at Website: https://bullfrogai.com LinkedIn: https://www.linkedin.com/company/bullfrogai/ Safe Harbor Statement This press release contains forward-looking statements. We base these forward-looking statements on our expectation...